GLMD
Price
$1.38
Change
-$0.08 (-5.48%)
Updated
Apr 4, 02:38 PM (EDT)
Capitalization
2.42M
33 days until earnings call
RCKT
Price
$5.17
Change
-$0.39 (-7.01%)
Updated
Apr 4, 04:54 PM (EDT)
Capitalization
591.79M
38 days until earnings call
Ad is loading...

GLMD vs RCKT

Header iconGLMD vs RCKT Comparison
Open Charts GLMD vs RCKTBanner chart's image
Galmed Pharmaceuticals
Price$1.38
Change-$0.08 (-5.48%)
Volume$400
Capitalization2.42M
Rocket Pharmaceuticals
Price$5.17
Change-$0.39 (-7.01%)
Volume$7.13K
Capitalization591.79M
GLMD vs RCKT Comparison Chart
Loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLMD vs. RCKT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GLMD: $1.46 vs. RCKT: $5.56)
Brand notoriety: GLMD and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 5% vs. RCKT: 245%
Market capitalization -- GLMD: $2.42M vs. RCKT: $591.79M
GLMD [@Biotechnology] is valued at $2.42M. RCKT’s [@Biotechnology] market capitalization is $591.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • GLMD’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLMD and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 3 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • GLMD’s TA Score: 3 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than GLMD.

Price Growth

GLMD (@Biotechnology) experienced а -13.10% price change this week, while RCKT (@Biotechnology) price change was -29.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

GLMD is expected to report earnings on May 07, 2025.

RCKT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($592M) has a higher market cap than GLMD($2.42M). GLMD (-54.232) and RCKT (-55.768) have similar YTD gains . GLMD has higher annual earnings (EBITDA): -6.7M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. GLMD (17.1M). GLMD has less debt than RCKT: GLMD (41K) vs RCKT (25.5M). GLMD (0) and RCKT (0) have equivalent revenues.
GLMDRCKTGLMD / RCKT
Capitalization2.42M592M0%
EBITDA-6.7M-247.48M3%
Gain YTD-54.232-55.76897%
P/E Ratio0.02N/A-
Revenue00-
Total Cash17.1M372M5%
Total Debt41K25.5M0%
FUNDAMENTALS RATINGS
GLMD vs RCKT: Fundamental Ratings
GLMD
RCKT
OUTLOOK RATING
1..100
9658
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
9595
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (27) in the Biotechnology industry is in the same range as GLMD (41) in the Pharmaceuticals Other industry. This means that RCKT’s stock grew similarly to GLMD’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLMD (100) in the Pharmaceuticals Other industry. This means that RCKT’s stock grew similarly to GLMD’s over the last 12 months.

RCKT's SMR Rating (97) in the Biotechnology industry is in the same range as GLMD (97) in the Pharmaceuticals Other industry. This means that RCKT’s stock grew similarly to GLMD’s over the last 12 months.

RCKT's Price Growth Rating (95) in the Biotechnology industry is in the same range as GLMD (95) in the Pharmaceuticals Other industry. This means that RCKT’s stock grew similarly to GLMD’s over the last 12 months.

GLMD's P/E Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as RCKT (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDRCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAIVX24.37N/A
N/A
Fidelity Advisor Equity Value I
PPUMX11.60N/A
N/A
Principal LargeCap Growth I R3
WFGGX26.36N/A
N/A
First Trust WCM Focused Global Gr Inv
MNSQX21.28N/A
N/A
Invesco Main Street Small Cap R5
ACWZX16.72N/A
N/A
AMG GW&K Small/Mid Cap Growth Z

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
-2.67%
XBIO - GLMD
88%
Closely correlated
-3.00%
IOBT - GLMD
35%
Loosely correlated
-6.07%
JSPR - GLMD
31%
Poorly correlated
-5.20%
RCKT - GLMD
29%
Poorly correlated
-11.75%
CDTX - GLMD
28%
Poorly correlated
N/A
More